FDA Label for Zituvimet Xr
View Indications, Usage & Precautions
Zituvimet Xr Product Label
The following document was submitted to the FDA by the labeler of this product Zydus Lifesciences Limited. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Package Label.Principal Display Panel
NDC 70771-1879-6
ZITUVIMET XR (sitagliptin and metformin hydrochloride extended-release) tablets
50 mg/500 mg
60 Tablets
Rx only
NDC 70771-1880-6
ZITUVIMET XR (sitagliptin and metformin hydrochloride extended-release) tablets
50 mg/1,000 mg
60 Tablets
Rx only
NDC 70771-1881-3
ZITUVIMET XR (sitagliptin and metformin hydrochloride extended-release) tablets
100 mg/1,000 mg
30 Tablets
Rx only
* Please review the disclaimer below.
